In fact, in hepatocellular carcinoma, cytoplasmatic MEF2C inhibited malignant cell proliferation, whereas nuclear MEF2C was associated with increased malignancy through angiogenesis and tumor invasion [16]. Here, MEF2C is linked to neoplasm.